The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Momenta Pharmaceuticals Inc

Nasdaq: MNTA
Last

(U.S.) $14.50

Today's change+0.20 +1.40%
Updated December 8 4:00 PM EST. Delayed by at least 15 minutes.
 

Momenta Pharmaceuticals Inc

Nasdaq: MNTA
Last

(U.S.) $14.50

Today's change+0.20 +1.40%
Updated December 8 4:00 PM EST. Delayed by at least 15 minutes.

Momenta Pharmaceuticals Inc up (U.S.)$0.20

Momenta Pharmaceuticals Inc closed up Thursday by (U.S.)$0.20 or 1.40% to (U.S.)$14.50. Over the last five days, shares have gained 5.07%, but are currently unchanged over the last year to date. Shares have underperformed the S&P 500 by 22.33% during the last year.

Key company metrics

  • Open(U.S.) $14.25
  • Previous close(U.S.) $14.30
  • High(U.S.) $14.65
  • Low(U.S.) $14.05
  • Bid / Ask(U.S.) $0.00 / (U.S.) $18.00
  • YTD % change-2.29%
  • Volume877,041
  • Average volume (10-day)554,538
  • Average volume (1-month)644,633
  • Average volume (3-month)614,792
  • 52-week range(U.S.) $7.86 to (U.S.) $16.95
  • Beta1.66
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$1.34
Updated December 8 4:00 PM EST. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue29262022
Total other revenue--------
Total revenue29262022
Gross profit--------
Total cost of revenue--------
Total operating expense47484452
Selling / general / administrative16151614
Research & development32332938
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-18-22-25-30
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-18-21-24-29
Income after tax-18-21-24-29
Income tax, total--------
Net income-18-21-24-29
Total adjustments to net income--------
Net income before extra. items-18-21-24-29
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-18-21-24-29
Inc. avail. to common incl. extra. items-18-21-24-29
Diluted net income-18-21-24-29
Dilution adjustment----0--
Diluted weighted average shares69696868
Diluted EPS excluding extraordinary itemsvalue per share-0.26-0.31-0.35-0.43
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.26-0.31-0.35-0.43